Ronald J. Daniels, Director at BridgeBio Pharma, Inc. (BBIO), bought 32,549 shares at $14.34 ($448K) on 2021-12-30, disclosed to the SEC on 2021-12-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.73 | 11,745 | $150K | 33.4% |
| 2 | $14.34 | 10,402 | $149K | 33.3% |
| 3 | $14.34 | 10,402 | $149K | 33.3% |
| Total | $13.76 avg | 32,549 | $448K | 100% |